Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cells

Non-small cell lung cancer (NSCLC) is the most deadly type of cancer worldwide. Although a number of therapies are used in NSCLC treatment, their therapeutic efficacy remains low. Lenalidomide was originally approved for use in patients with myelodysplastic syndromes, which are associated with 5q de...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: KIM, KARAM, AN, SUNGKWAN, CHA, HWA JUN, CHOI, YEONG MIN, CHOI, SUNG JIN, AN, IN-SOOK, LEE, HONG GHI, MIN, YOO HONG, LEE, SU-JAE, BAE, SEUNGHEE
Формат: Artigo
Язык:Inglês
Опубликовано: D.A. Spandidos 2013
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3573063/
https://ncbi.nlm.nih.gov/pubmed/23420263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2012.1054
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы